» Articles » PMID: 37924488

Autophagy Induced by Helicobacter Pylori Infection Can Lead to Gastric Cancer Dormancy, Metastasis, and Recurrence: New Insights

Overview
Journal Hum Cell
Publisher Springer
Specialty Cell Biology
Date 2023 Nov 4
PMID 37924488
Authors
Affiliations
Soon will be listed here.
Abstract

According to the findings of recent research, Helicobacter Pylori (H. pylori) infection is not only the primary cause of gastric cancer (GC), but it is also linked to the spread and invasion of GC through a number of processes and factors that contribute to virulence. In this study, we discussed that H. pylori infection can increase autophagy in GC tumor cells, leading to poor prognosis in such patients. Until now, the main concerns have been focused on H. pylori's role in GC development. According to our hypothesis, however, H. pylori infection may also lead to GC dormancy, metastasis, and recurrence by stimulating autophagy. Therefore, understanding how H. pylori possess these processes through its virulence factors and various microRNAs can open new windows for providing new prevention and/or therapeutic approaches to combat GC dormancy, metastasis, and recurrence which can occur in GC patients with H. pylori infection with targeting autophagy and eradicating H. pylori infection.

Citing Articles

Potential mechanism of traditional Chinese medicine intervention in gastric cancer: targeted regulation of autophagy.

Sun S, Yu W, Zhang G, Li X, Song L, Lv Y Front Pharmacol. 2025; 16:1548672.

PMID: 40066330 PMC: 11891941. DOI: 10.3389/fphar.2025.1548672.


Autophagy induced by metabolic processes leads to solid tumor cell metastatic dormancy and recurrence.

Ferdousmakan S, Mansourian D, Seyedi Asl F, Fathi Z, Maleki-Sheikhabadi F, Nabi Afjadi M Med Oncol. 2025; 42(3):62.

PMID: 39899220 DOI: 10.1007/s12032-025-02607-6.


Reactive oxygen species induced by SARS-CoV-2 infection can induce EMT in solid tumors: Potential role of COVID-19 in chemo-resistance and metastasis.

Moulaeian M, Ferdousmakan S, Banihashemi S, Homayounfar S, Pasupulla A, Malekzadegan Y Heliyon. 2024; 10(22):e40297.

PMID: 39624316 PMC: 11609686. DOI: 10.1016/j.heliyon.2024.e40297.


Increased V-ATPase activity can lead to chemo-resistance in oral squamous cell carcinoma via autophagy induction: new insights.

Lagzian A, Askari M, Haeri M, Sheikhi N, Banihashemi S, Nabi-Afjadi M Med Oncol. 2024; 41(5):108.

PMID: 38592406 DOI: 10.1007/s12032-024-02313-9.

References
1.
Karami Fath M, Babakhaniyan K, Zokaei M, Yaghoubian A, Akbari S, Khorsandi M . Anti-cancer peptide-based therapeutic strategies in solid tumors. Cell Mol Biol Lett. 2022; 27(1):33. PMC: 8994312. DOI: 10.1186/s11658-022-00332-w. View

2.
Zalpoor H, Nabi-Afjadi M, Forghaniesfidvajani R, Tavakol C, Farahighasreaboonasr F, Pakizeh F . Quercetin as a JAK-STAT inhibitor: a potential role in solid tumors and neurodegenerative diseases. Cell Mol Biol Lett. 2022; 27(1):60. PMC: 9327369. DOI: 10.1186/s11658-022-00355-3. View

3.
Eyvazi S, Mahdi Khamaneh A, Tarhriz V, Bandehpour M, Hejazi M, Eftekhar Sadat A . CpG Islands Methylation Analysis of CDH11, EphA5, and HS3ST2 Genes in Gastric Adenocarcinoma Patients. J Gastrointest Cancer. 2019; 51(2):579-583. DOI: 10.1007/s12029-019-00290-1. View

4.
Kanaji S, Suzuki S, Matsuda Y, Hasegawa H, Yamamoto M, Yamashita K . Recent updates in perioperative chemotherapy and recurrence pattern of gastric cancer. Ann Gastroenterol Surg. 2018; 2(6):400-405. PMC: 6236108. DOI: 10.1002/ags3.12199. View

5.
Paoletti X, Oba K, Burzykowski T, Michiels S, Ohashi Y, Pignon J . Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis. JAMA. 2010; 303(17):1729-37. DOI: 10.1001/jama.2010.534. View